Search Results

In a tough labor market where layoffs continue, some are considering—or even moving—from industry to academia, according to a BioSpace poll. A career coach, scientist and general practitioner turned research coordinator share their thoughts.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, announced it has acquired Norman, Oklahoma-based Bio-Cide International, Inc., a leading multi-specialty source of chlorine dioxide-based antimicrobial technology.

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug price negotiation program.

Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the insatiable demand for weight loss drugs.

Kemin, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, announced its Neumentix™ Phenolic Complex K110-42, a patent-pending spearmint extract containing a proprietary phenolic complex, has been approved by Health Canada, bringing the ingredient for brain health to consumers in Canada.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, with its subsidiary Kemin Biologics, has signed an exclusive agreement with Pacific GeneTech (PGT) to license PGT’s TMH001 Eimeria vaccine for poultry

M&A activity surges and IPOs return as the biotech industry navigates a changing business landscape marked by strategic consolidation and renewed investor focus on innovation.

Despite an uncertain legislative path to becoming law, the BIOSECURE Act has already impacted the biopharma industry’s confidence in Chinese service providers and prompted efforts to diversify manufacturing partners.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has announced the publication of a clinical study on Kemin Human Nutrition and Health’s DailyZz™ sleep ingredient.